Revelation Historical Financial Ratios

REVB Stock  USD 0.76  0.01  0.67%   
Revelation Biosciences is promptly reporting on over 90 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 27.7, Invested Capital of 0.0, Average Payables of 556 K or Stock Based Compensation To Revenue of 0.0 will help investors to properly organize and evaluate Revelation Biosciences financial condition quickly.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.

About Revelation Financial Ratios Analysis

Revelation BiosciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Revelation Biosciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Revelation financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Revelation Biosciences history.

Revelation Biosciences Financial Ratios Chart

At present, Revelation Biosciences' PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's PB Ratio is expected to grow to 0.54, whereas Book Value Per Share is forecasted to decline to 27.70.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.
Most ratios from Revelation Biosciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Revelation Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.At present, Revelation Biosciences' PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's PB Ratio is expected to grow to 0.54, whereas Book Value Per Share is forecasted to decline to 27.70.
 2021 2022 2023 2024 (projected)
Current Ratio0.891.222.182.23
Net Debt To EBITDA0.110.48125.95132.25

Revelation Biosciences fundamentals Correlations

0.49-0.71-0.520.76-0.721.0-0.510.74-0.56-0.67-0.820.850.720.850.60.570.330.851.0-0.460.85-0.410.36-0.810.49
0.49-0.040.08-0.04-0.030.490.080.16-0.060.00.06-0.040.03-0.04-0.01-0.02-0.12-0.040.480.06-0.04-0.07-0.010.051.0
-0.71-0.040.24-0.690.98-0.710.23-0.240.190.860.75-0.83-0.98-0.83-0.71-0.650.16-0.83-0.710.08-0.830.7-0.470.72-0.04
-0.520.080.24-0.790.14-0.521.0-0.860.990.00.5-0.62-0.14-0.620.10.12-0.84-0.61-0.530.98-0.610.440.40.820.08
0.76-0.04-0.69-0.79-0.640.76-0.790.75-0.76-0.51-0.80.90.640.90.380.340.520.90.77-0.710.9-0.60.06-0.96-0.04
-0.72-0.030.980.14-0.64-0.720.14-0.230.090.940.81-0.83-1.0-0.83-0.83-0.790.17-0.84-0.710.0-0.840.54-0.630.67-0.03
1.00.49-0.71-0.520.76-0.72-0.510.74-0.56-0.67-0.820.850.720.850.60.570.330.851.0-0.460.85-0.410.36-0.810.49
-0.510.080.231.0-0.790.14-0.51-0.860.990.00.5-0.61-0.14-0.610.10.12-0.84-0.61-0.530.98-0.610.440.40.820.08
0.740.16-0.24-0.860.75-0.230.74-0.86-0.89-0.23-0.70.710.230.710.220.220.880.710.75-0.890.71-0.13-0.01-0.810.16
-0.56-0.060.190.99-0.760.09-0.560.99-0.89-0.040.47-0.58-0.09-0.580.130.15-0.86-0.58-0.570.99-0.580.40.410.79-0.06
-0.670.00.860.0-0.510.94-0.670.0-0.23-0.040.84-0.79-0.94-0.79-0.97-0.950.14-0.79-0.67-0.09-0.790.23-0.850.560.0
-0.820.060.750.5-0.80.81-0.820.5-0.70.470.84-0.97-0.81-0.97-0.81-0.79-0.41-0.97-0.830.45-0.970.25-0.580.870.06
0.85-0.04-0.83-0.620.9-0.830.85-0.610.71-0.58-0.79-0.970.831.00.690.660.41.00.85-0.531.0-0.480.42-0.95-0.04
0.720.03-0.98-0.140.64-1.00.72-0.140.23-0.09-0.94-0.810.830.830.830.79-0.170.840.710.00.84-0.540.63-0.670.03
0.85-0.04-0.83-0.620.9-0.830.85-0.610.71-0.58-0.79-0.971.00.830.690.660.41.00.85-0.531.0-0.480.42-0.95-0.04
0.6-0.01-0.710.10.38-0.830.60.10.220.13-0.97-0.810.690.830.691.0-0.10.70.590.150.70.010.94-0.44-0.01
0.57-0.02-0.650.120.34-0.790.570.120.220.15-0.95-0.790.660.790.661.0-0.080.670.560.160.670.080.96-0.41-0.02
0.33-0.120.16-0.840.520.170.33-0.840.88-0.860.14-0.410.4-0.170.4-0.1-0.080.40.35-0.920.40.11-0.26-0.57-0.12
0.85-0.04-0.83-0.610.9-0.840.85-0.610.71-0.58-0.79-0.971.00.841.00.70.670.40.85-0.531.0-0.470.42-0.95-0.04
1.00.48-0.71-0.530.77-0.711.0-0.530.75-0.57-0.67-0.830.850.710.850.590.560.350.85-0.480.85-0.410.35-0.810.48
-0.460.060.080.98-0.710.0-0.460.98-0.890.99-0.090.45-0.530.0-0.530.150.16-0.92-0.53-0.48-0.530.270.410.740.06
0.85-0.04-0.83-0.610.9-0.840.85-0.610.71-0.58-0.79-0.971.00.841.00.70.670.41.00.85-0.53-0.470.42-0.95-0.04
-0.41-0.070.70.44-0.60.54-0.410.44-0.130.40.230.25-0.48-0.54-0.480.010.080.11-0.47-0.410.27-0.470.290.56-0.07
0.36-0.01-0.470.40.06-0.630.360.4-0.010.41-0.85-0.580.420.630.420.940.96-0.260.420.350.410.420.29-0.12-0.01
-0.810.050.720.82-0.960.67-0.810.82-0.810.790.560.87-0.95-0.67-0.95-0.44-0.41-0.57-0.95-0.810.74-0.950.56-0.120.05
0.491.0-0.040.08-0.04-0.030.490.080.16-0.060.00.06-0.040.03-0.04-0.01-0.02-0.12-0.040.480.06-0.04-0.07-0.010.05
Click cells to compare fundamentals

Revelation Biosciences Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Revelation Biosciences is a strong investment it is important to analyze Revelation Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Revelation Biosciences' future performance. For an informed investment choice regarding Revelation Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revelation Biosciences. If investors know Revelation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revelation Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(17.53)
Return On Assets
(0.51)
Return On Equity
(2.70)
The market value of Revelation Biosciences is measured differently than its book value, which is the value of Revelation that is recorded on the company's balance sheet. Investors also form their own opinion of Revelation Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Revelation Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revelation Biosciences' market value can be influenced by many factors that don't directly affect Revelation Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revelation Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Revelation Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revelation Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.